Regeneron Pharmaceuticals Inc (NASDAQ:REGN)
| 612.71 BATS BZX Real-Time Price As of 10:56am ET |  -5.97 / -0.96%Today’s Change | 441.00 Today|||52-Week Range 686.62 | +26.83% Year-to-Date |
Latest REGN News | Press Releases
Today’s Trading
| Previous close | 618.68 |
| Today’s open | 605.53 |
| Day’s range | 604.20 - 617.76 |
| Volume | 13,294 |
| Average volume (3 months) | 753,061 |
| Market cap | $68.3B |
Data as of 10:56am ET, 09/28/2021
Growth & Valuation
| Earnings growth (last year) | +68.51% |
| Earnings growth (this year) | +91.12% |
| Earnings growth (next 5 years) | +4.00% |
| Revenue growth (last year) | +8.06% |
| P/E ratio | 11.0 |
| Price/Sales | 6.54 |
| Price/Book | 6.20 |
Financials
| Next reporting date | November 9, 2021 |
| EPS forecast (this quarter) | $9.95 |
| Annual revenue (last year) | $8.5B |
| Annual profit (last year) | $3.5B |
| Net profit margin | 41.35% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Tarrytown, New York |
Forecasts
